Road to 2025: Control Bionics’ breakout into sports science
Stockhead TV
share
Stockhead’s Road to 2025 video series highlights companies’ key 2024 achievements and the routes they’re plotting towards a successful year ahead.
In this episode, Sarah Hughan covers Control Bionics (ASX:CBL) whose cutting-edge EMG-based technologies are designed to empower individuals with severe disabilities.
This year saw Control Bionics break into new markets like sports science and health diagnostics.
Tune in to find out what to look out for in 2025.
This video was developed in collaboration with Control Bionics a Stockhead advertiser at the time of publishing.
The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.
